Congestive Heart Failure (CHF) Treatment Devices Market Analysis by Product (Ventricular Assist Devices, Counter Pulsation Devices, Implantable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization Therapy) And Segment Forecasts to 2024
The congestive heart failure (CHF) treatment devices market is expected to reach USD 32.0 billion by 2024, according to a new report by Grand View Research, Inc. The rising burden of CVDs is one of the prime factors responsible for lucrative growth of this vertical. Sedentary lifestyles, mental stress, and junk food consumption tendencies are the key factors responsible for development of CVDs.
Favorable reimbursement policies, such as the U.S. Medicare system, are observed to be a prime growth factor for this industry. Companies now provide new product platforms, which have reimbursement coverage that benefit the patient. The reimbursement can be availed for devices, such as Ventricular Assist Devices (VADs), Implantable Cardiovascular Defibrillators (ICDs), and pacemakers, which are used to treat CHF.
The industry participants are more focused on developing high-utility products, which can deliver personalized care. These advancements are improving the accuracy and provide additional capabilities to enhance the workflow and reduce the incidence of errors.
Further key findings from the study suggest:
The market by product is segmented into VADs, Counter Pulsation Devices, ICDs, pacemakers, and cardiac resynchronization devices. The ICD segment consisting of two types, transvenous and subcutaneous, held a lucrative share in 2015, which was followed by the pacemaker’s segment. This can be attributed to the fact that defibrillators and pacemakers form the primary line of treatment administered for heart failure.
On the other hand, the VAD segment is anticipated to grow at a significant rate over the forecast period due to reimbursement coverage and technological advancements in VADs.
The VAD based on the site of implantation are categorized into Left Ventricular Assist Devices (LVAD) and Right Ventricular Assist Devices (RVAD). When the LVAD and RVAD are implanted together they are termed Biventricular Assist Devices (BIVAD).
North America dominated the overall market in terms of revenue share at over 40.0% in 2015; this can be attributed to the presence of a large population base suffering from CVDs coupled with a significant geriatric population base.
Asia-Pacific is anticipated to grow at a lucrative CAGR during the forecast period due to the increasing demand for these products. Furthermore, the rapidly improving healthcare infrastructure in the countries, such as India and Japan, also contribute toward the growth of this region.
Some of the players in this industry are Berlin Heart Inc., Medtronic, Boston Scientific, World Heart Corporation, Biotronik, Jarvik Heart, MicroMed Cardiovascular Inc., Teleflex Inc., and St. Jude Medical.
The market participants are actively involved in the improvement of the current product portfolio, in order to sustain their market position. Additionally, drug development and their market entry in the untapped nations are expected to propel market growth.
Favorable reimbursement policies, such as the U.S. Medicare system, are observed to be a prime growth factor for this industry. Companies now provide new product platforms, which have reimbursement coverage that benefit the patient. The reimbursement can be availed for devices, such as Ventricular Assist Devices (VADs), Implantable Cardiovascular Defibrillators (ICDs), and pacemakers, which are used to treat CHF.
The industry participants are more focused on developing high-utility products, which can deliver personalized care. These advancements are improving the accuracy and provide additional capabilities to enhance the workflow and reduce the incidence of errors.
Further key findings from the study suggest:
The market by product is segmented into VADs, Counter Pulsation Devices, ICDs, pacemakers, and cardiac resynchronization devices. The ICD segment consisting of two types, transvenous and subcutaneous, held a lucrative share in 2015, which was followed by the pacemaker’s segment. This can be attributed to the fact that defibrillators and pacemakers form the primary line of treatment administered for heart failure.
On the other hand, the VAD segment is anticipated to grow at a significant rate over the forecast period due to reimbursement coverage and technological advancements in VADs.
The VAD based on the site of implantation are categorized into Left Ventricular Assist Devices (LVAD) and Right Ventricular Assist Devices (RVAD). When the LVAD and RVAD are implanted together they are termed Biventricular Assist Devices (BIVAD).
North America dominated the overall market in terms of revenue share at over 40.0% in 2015; this can be attributed to the presence of a large population base suffering from CVDs coupled with a significant geriatric population base.
Asia-Pacific is anticipated to grow at a lucrative CAGR during the forecast period due to the increasing demand for these products. Furthermore, the rapidly improving healthcare infrastructure in the countries, such as India and Japan, also contribute toward the growth of this region.
Some of the players in this industry are Berlin Heart Inc., Medtronic, Boston Scientific, World Heart Corporation, Biotronik, Jarvik Heart, MicroMed Cardiovascular Inc., Teleflex Inc., and St. Jude Medical.
The market participants are actively involved in the improvement of the current product portfolio, in order to sustain their market position. Additionally, drug development and their market entry in the untapped nations are expected to propel market growth.
CHAPTER 1 RESEARCH METHODOLOGY
1.1 Information procurement
1.2 Data Analysis
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 MARKET SNAPSHOT
CHAPTER 4 MARKET VARIABLES, TRENDS& SCOPE
4.1 Market segmentation & scope
4.1.1 Market Driver Analysis
4.1.1.1 Rising prevalence of cardiovascular diseases (CVD)
4.1.1.2 Favorable reimbursement policies
4.1.1.3 Advent of technological advanced products
4.1.1.4 Growing geriatric population base
4.1.2 Market Restraint Analysis
4.1.2.1 Stringent regulation and approval
4.1.2.2 High cost of devices
4.2 CHF treatment devices market: Company market share, 2015
4.3 Penetration & growth prospect mapping
4.4 CHF Treatment Devices - SWOT Analysis, By Factor (political & legal, economic and technological)
4.5 Industry Analysis - Porter’s
CHAPTER 5 MARKET CATEGORIZATION : PRODUCT ESTIMATES & TREND ANALYSIS
5.1 Congestive Heart Failure Treatment Devices Market: Product movement analysis
5.2 Ventricular assist devices (VAD)
5.2.1 Ventricular assist devices market, 2013 - 2024 (USD Million)
5.2.2 Left Ventricular Assist Devices (LVAD)
5.2.2.1 Left Ventricular Assist Devices market, 2013 - 2024 (USD Million)
5.2.3 Right Ventricular Assist Devices (RVAD)
5.2.3.1 Right Ventricular Assist Devices market, 2013 - 2024 (USD Million)
5.2.4 Biventricular Assist Devices (BIVAD)
5.2.4.1 Biventricular Assist Devices market, 2013 - 2024 (USD Million)
5.3 Counter Pulsation Devices
5.3.1 Counter pulsation devices market, 2013 - 2024 (USD Million)
5.4 Implantable Cardioverter Defibrillators (ICD)
5.4.1 Implantable cardioverter defibrillators market, 2013 - 2024 (USD Million)
5.4.2 Transvenous ICDs
5.4.2.1 Transvenous ICDs market, 2013 - 2024 (USD Million)
5.4.3 Subcutaneous ICDs
5.4.3.1 Subcutaneous ICDs market, 2013 - 2024 (USD Million)
5.5 Pacemakers
5.5.1 Pacemakers market, 2013 - 2024 (USD Million)
5.5.2 Implantable pacemakers
5.5.2.1 Implantable pacemakers market, 2013 - 2024 (USD Million)
5.5.3 External pacemakers
5.5.3.1 External pacemakers market, 2013 - 2024 (USD Million)
5.6 Cardiac Resynchronization Therapy (CRT)
5.6.1 Cardiac resynchronization therapy market, 2013 - 2024 (USD Million)
5.6.2 Cardiac Resynchronization Therapy-Defibrillators (CRT-D)
5.6.2.1 CRT-D market, 2013 - 2024 (USD Million)
5.6.3 Cardiac Resynchronization Therapy-Pacemakers (CRT-P)
5.6.3.1 CRT-P market, 2013 - 2024 (USD Million)
CHAPTER 6 MARKET CATEGORIZATION: REGIONAL ESTIMATES & TREND ANALYSIS, BY PRODUCT
6.1 Congestive heart failure treatment devices market share by region, 2015 & 2024
6.2 North America
6.2.1 North America CHF treatment devices market, 2013 - 2024 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. CHF treatment devices market, 2013 - 2024 (USD Million)
6.2.3 Canada
6.2.3.1 Canada CHF treatment devices market, 2013 - 2024 (USD Million)
6.3 Europe
6.3.1 Europe CHF treatment devices market, 2013 - 2024 (USD Million)
6.3.2 UK
6.3.2.1 UK CHF treatment devices market, 2013 - 2024 (USD Million)
6.3.3 Germany
6.3.4 Germany CHF treatment devices market, 2013 - 2024 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific CHF treatment devices market, 2013 - 2024 (USD Million)
6.4.2 Japan
6.4.2.1 Japan CHF treatment devices market, 2013 - 2024 (USD Million)
6.4.3 China
6.4.3.1 China CHF treatment devices market, 2013 - 2024 (USD Million)
6.5 Latin America
6.5.1 Latin America CHF treatment devices market, 2013 - 2024 (USD Million)
6.5.2 Brazil
6.5.3 Brazil CHF treatment devices market, 2013 - 2024 (USD Million)
6.5.4 Mexico
6.5.4.1 Mexico CHF treatment devices market, 2013 - 2024 (USD Million)
6.6 MEA
6.6.1 MEA CHF treatment devices market, 2013 - 2024 (USD Million)
6.6.2 South Africa
6.6.3 South Africa ca CHF treatment devices market, 2013 - 2024 (USD Million)
6.7 Saudi Arabia
6.7.1 Saudi Arabia CHF treatment devices market, 2013 - 2024 (USD Million)
CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 Strategy framework
7.2 Market participant categorization
7.2.1 Jarvik Heart Inc.
7.2.1.1 Company Overview
7.2.1.2 Financial Performance
7.2.1.3 Product Benchmarking
7.2.1.4 Strategic initiatives
7.2.2 ReliantHeart, Inc.
7.2.2.1 Company Overview
7.2.2.2 Financial Performance
7.2.2.3 Product Benchmarking
7.2.2.4 Strategic Initiatives
7.2.3 Biotronik SE & Co., KG
7.2.3.1 Company Overview
7.2.3.2 Financial Performance
7.2.3.3 Product Benchmarking
7.2.3.4 Strategic Initiatives
7.2.3.5 Additional Information
7.2.4 Berlin Heart GmbH
7.2.4.1 Company Overview
7.2.4.2 Financial Performance
7.2.4.3 Product Benchmarking
7.2.5 St. Jude Medical, Inc.
7.2.5.1 Company Overview
7.2.5.2 Financial Performance
7.2.5.3 Product Benchmarking
7.2.5.4 Financial Performance
7.2.6 Medtronic
7.2.6.1 Company Overview
7.2.6.2 Financial Performance
7.2.6.3 Product Benchmarking
7.2.6.4 Strategic Initiatives
7.2.7 Boston Scientific Corporation
7.2.7.1 Company Overview
7.2.7.2 Financial Performance
7.2.7.3 Product Benchmarking
7.2.7.4 Strategic Initiatives
7.2.8 Teleflex, Inc.
7.2.8.1 Company Overview
7.2.8.2 Financial Performance
7.2.8.3 Product Benchmarking
7.2.8.4 Strategic Initiatives
1.1 Information procurement
1.2 Data Analysis
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 MARKET SNAPSHOT
CHAPTER 4 MARKET VARIABLES, TRENDS& SCOPE
4.1 Market segmentation & scope
4.1.1 Market Driver Analysis
4.1.1.1 Rising prevalence of cardiovascular diseases (CVD)
4.1.1.2 Favorable reimbursement policies
4.1.1.3 Advent of technological advanced products
4.1.1.4 Growing geriatric population base
4.1.2 Market Restraint Analysis
4.1.2.1 Stringent regulation and approval
4.1.2.2 High cost of devices
4.2 CHF treatment devices market: Company market share, 2015
4.3 Penetration & growth prospect mapping
4.4 CHF Treatment Devices - SWOT Analysis, By Factor (political & legal, economic and technological)
4.5 Industry Analysis - Porter’s
CHAPTER 5 MARKET CATEGORIZATION : PRODUCT ESTIMATES & TREND ANALYSIS
5.1 Congestive Heart Failure Treatment Devices Market: Product movement analysis
5.2 Ventricular assist devices (VAD)
5.2.1 Ventricular assist devices market, 2013 - 2024 (USD Million)
5.2.2 Left Ventricular Assist Devices (LVAD)
5.2.2.1 Left Ventricular Assist Devices market, 2013 - 2024 (USD Million)
5.2.3 Right Ventricular Assist Devices (RVAD)
5.2.3.1 Right Ventricular Assist Devices market, 2013 - 2024 (USD Million)
5.2.4 Biventricular Assist Devices (BIVAD)
5.2.4.1 Biventricular Assist Devices market, 2013 - 2024 (USD Million)
5.3 Counter Pulsation Devices
5.3.1 Counter pulsation devices market, 2013 - 2024 (USD Million)
5.4 Implantable Cardioverter Defibrillators (ICD)
5.4.1 Implantable cardioverter defibrillators market, 2013 - 2024 (USD Million)
5.4.2 Transvenous ICDs
5.4.2.1 Transvenous ICDs market, 2013 - 2024 (USD Million)
5.4.3 Subcutaneous ICDs
5.4.3.1 Subcutaneous ICDs market, 2013 - 2024 (USD Million)
5.5 Pacemakers
5.5.1 Pacemakers market, 2013 - 2024 (USD Million)
5.5.2 Implantable pacemakers
5.5.2.1 Implantable pacemakers market, 2013 - 2024 (USD Million)
5.5.3 External pacemakers
5.5.3.1 External pacemakers market, 2013 - 2024 (USD Million)
5.6 Cardiac Resynchronization Therapy (CRT)
5.6.1 Cardiac resynchronization therapy market, 2013 - 2024 (USD Million)
5.6.2 Cardiac Resynchronization Therapy-Defibrillators (CRT-D)
5.6.2.1 CRT-D market, 2013 - 2024 (USD Million)
5.6.3 Cardiac Resynchronization Therapy-Pacemakers (CRT-P)
5.6.3.1 CRT-P market, 2013 - 2024 (USD Million)
CHAPTER 6 MARKET CATEGORIZATION: REGIONAL ESTIMATES & TREND ANALYSIS, BY PRODUCT
6.1 Congestive heart failure treatment devices market share by region, 2015 & 2024
6.2 North America
6.2.1 North America CHF treatment devices market, 2013 - 2024 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. CHF treatment devices market, 2013 - 2024 (USD Million)
6.2.3 Canada
6.2.3.1 Canada CHF treatment devices market, 2013 - 2024 (USD Million)
6.3 Europe
6.3.1 Europe CHF treatment devices market, 2013 - 2024 (USD Million)
6.3.2 UK
6.3.2.1 UK CHF treatment devices market, 2013 - 2024 (USD Million)
6.3.3 Germany
6.3.4 Germany CHF treatment devices market, 2013 - 2024 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific CHF treatment devices market, 2013 - 2024 (USD Million)
6.4.2 Japan
6.4.2.1 Japan CHF treatment devices market, 2013 - 2024 (USD Million)
6.4.3 China
6.4.3.1 China CHF treatment devices market, 2013 - 2024 (USD Million)
6.5 Latin America
6.5.1 Latin America CHF treatment devices market, 2013 - 2024 (USD Million)
6.5.2 Brazil
6.5.3 Brazil CHF treatment devices market, 2013 - 2024 (USD Million)
6.5.4 Mexico
6.5.4.1 Mexico CHF treatment devices market, 2013 - 2024 (USD Million)
6.6 MEA
6.6.1 MEA CHF treatment devices market, 2013 - 2024 (USD Million)
6.6.2 South Africa
6.6.3 South Africa ca CHF treatment devices market, 2013 - 2024 (USD Million)
6.7 Saudi Arabia
6.7.1 Saudi Arabia CHF treatment devices market, 2013 - 2024 (USD Million)
CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 Strategy framework
7.2 Market participant categorization
7.2.1 Jarvik Heart Inc.
7.2.1.1 Company Overview
7.2.1.2 Financial Performance
7.2.1.3 Product Benchmarking
7.2.1.4 Strategic initiatives
7.2.2 ReliantHeart, Inc.
7.2.2.1 Company Overview
7.2.2.2 Financial Performance
7.2.2.3 Product Benchmarking
7.2.2.4 Strategic Initiatives
7.2.3 Biotronik SE & Co., KG
7.2.3.1 Company Overview
7.2.3.2 Financial Performance
7.2.3.3 Product Benchmarking
7.2.3.4 Strategic Initiatives
7.2.3.5 Additional Information
7.2.4 Berlin Heart GmbH
7.2.4.1 Company Overview
7.2.4.2 Financial Performance
7.2.4.3 Product Benchmarking
7.2.5 St. Jude Medical, Inc.
7.2.5.1 Company Overview
7.2.5.2 Financial Performance
7.2.5.3 Product Benchmarking
7.2.5.4 Financial Performance
7.2.6 Medtronic
7.2.6.1 Company Overview
7.2.6.2 Financial Performance
7.2.6.3 Product Benchmarking
7.2.6.4 Strategic Initiatives
7.2.7 Boston Scientific Corporation
7.2.7.1 Company Overview
7.2.7.2 Financial Performance
7.2.7.3 Product Benchmarking
7.2.7.4 Strategic Initiatives
7.2.8 Teleflex, Inc.
7.2.8.1 Company Overview
7.2.8.2 Financial Performance
7.2.8.3 Product Benchmarking
7.2.8.4 Strategic Initiatives
LIST OF TABLES
TABLE 1 Inpatient cardiovascular surgeries in the U.S
TABLE 2 Number and percentage of deaths from cardiovascular diseases in Europe
TABLE 3 Counter pulsation devices types, mechanism and intended use
TABLE 4 North America CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 5 North America VADs market, by product, 2013 - 2024 (USD Million)
TABLE 6 North America ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 7 North America pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 8 North America CRT market, by product, 2013 - 2024 (USD Million)
TABLE 9 U.S. CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 10 U.S. VADs market, by product, 2013 - 2024 (USD Million)
TABLE 11 U.S.ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 12 U.S. pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 13 U.S. CRT market, by product, 2013 - 2024 (USD Million)
TABLE 14 Canada CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 15 Canada VADs market, by product, 2013 - 2024 (USD Million)
TABLE 16 Canada ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 17 Canada pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 18 Canada CRT market, by product, 2013 - 2024 (USD Million)
TABLE 19 Europe CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 20 Europe VADs market, by product, 2013 - 2024 (USD Million)
TABLE 21 Europe ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 22 Europe pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 23 Europe CRT market, by product, 2013 - 2024 (USD Million)
TABLE 24 UK CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 25 UK VADs market, by product, 2013 - 2024 (USD Million)
TABLE 26 UK ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 27 UK pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 28 UK CRT market, by product, 2013 - 2024 (USD Million)
TABLE 29 Germany CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 30 Germany VADs market, by product, 2013 - 2024 (USD Million)
TABLE 31 Germany ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 32 Germany pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 33 Germany CRT market, by product, 2013 - 2024 (USD Million)
TABLE 34 Asia Pacific CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 35 Asia Pacific VADs market, by product, 2013 - 2024 (USD Million)
TABLE 36 Asia Pacific ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 37 Asia Pacific pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 38 Asia Pacific CRT market, by product, 2013 - 2024 (USD Million)
TABLE 39 Japan CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 40 Japan VADs market, by product, 2013 - 2024 (USD Million)
TABLE 41 Japan ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 42 Japan pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 43 Japan CRT market, by product, 2013 - 2024 (USD Million)
TABLE 44 China CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 45 China VADs market, by product, 2013 - 2024 (USD Million)
TABLE 46 China ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 47 China pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 48 China CRT market, by product, 2013 - 2024 (USD Million)
TABLE 49 Latin America CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 50 Latin America VADs market, by product, 2013 - 2024 (USD Million)
TABLE 51 Latin America ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 52 Latin America pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 53 Latin America CRT market, by product, 2013 - 2024 (USD Million)
TABLE 54 Brazil CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 55 Brazil VADs market, by product, 2013 - 2024 (USD Million)
TABLE 56 Brazil ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 57 Brazil pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 58 Brazil CRT market, by product, 2013 - 2024 (USD Million)
TABLE 59 Mexico CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 60 Mexico VADs market, by product, 2013 - 2024 (USD Million)
TABLE 61 Mexico ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 62 Mexico pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 63 Mexico CRT market, by product, 2013 - 2024 (USD Million)
TABLE 64 MEA CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 65 MEA VADs market, by product, 2013 - 2024 (USD Million)
TABLE 66 MEA ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 67 MEA pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 68 MEA CRT market, by product, 2013 - 2024 (USD Million)
TABLE 69 South Africa CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 70 South Africa VADs market, by product, 2013 - 2024 (USD Million)
TABLE 71 South Africa ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 72 South Africa pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 73 South Africa CRT market, by product, 2013 - 2024 (USD Million)
TABLE 74 Saudi Arabia CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 75 Saudi Arabia VADs market, by product, 2013 - 2024 (USD Million)
TABLE 76 Saudi Arabia ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 77 Saudi Arabia pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 78 Saudi Arabia CRT market, by product, 2013 - 2024 (USD Million)
TABLE 1 Inpatient cardiovascular surgeries in the U.S
TABLE 2 Number and percentage of deaths from cardiovascular diseases in Europe
TABLE 3 Counter pulsation devices types, mechanism and intended use
TABLE 4 North America CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 5 North America VADs market, by product, 2013 - 2024 (USD Million)
TABLE 6 North America ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 7 North America pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 8 North America CRT market, by product, 2013 - 2024 (USD Million)
TABLE 9 U.S. CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 10 U.S. VADs market, by product, 2013 - 2024 (USD Million)
TABLE 11 U.S.ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 12 U.S. pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 13 U.S. CRT market, by product, 2013 - 2024 (USD Million)
TABLE 14 Canada CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 15 Canada VADs market, by product, 2013 - 2024 (USD Million)
TABLE 16 Canada ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 17 Canada pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 18 Canada CRT market, by product, 2013 - 2024 (USD Million)
TABLE 19 Europe CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 20 Europe VADs market, by product, 2013 - 2024 (USD Million)
TABLE 21 Europe ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 22 Europe pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 23 Europe CRT market, by product, 2013 - 2024 (USD Million)
TABLE 24 UK CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 25 UK VADs market, by product, 2013 - 2024 (USD Million)
TABLE 26 UK ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 27 UK pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 28 UK CRT market, by product, 2013 - 2024 (USD Million)
TABLE 29 Germany CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 30 Germany VADs market, by product, 2013 - 2024 (USD Million)
TABLE 31 Germany ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 32 Germany pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 33 Germany CRT market, by product, 2013 - 2024 (USD Million)
TABLE 34 Asia Pacific CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 35 Asia Pacific VADs market, by product, 2013 - 2024 (USD Million)
TABLE 36 Asia Pacific ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 37 Asia Pacific pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 38 Asia Pacific CRT market, by product, 2013 - 2024 (USD Million)
TABLE 39 Japan CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 40 Japan VADs market, by product, 2013 - 2024 (USD Million)
TABLE 41 Japan ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 42 Japan pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 43 Japan CRT market, by product, 2013 - 2024 (USD Million)
TABLE 44 China CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 45 China VADs market, by product, 2013 - 2024 (USD Million)
TABLE 46 China ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 47 China pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 48 China CRT market, by product, 2013 - 2024 (USD Million)
TABLE 49 Latin America CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 50 Latin America VADs market, by product, 2013 - 2024 (USD Million)
TABLE 51 Latin America ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 52 Latin America pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 53 Latin America CRT market, by product, 2013 - 2024 (USD Million)
TABLE 54 Brazil CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 55 Brazil VADs market, by product, 2013 - 2024 (USD Million)
TABLE 56 Brazil ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 57 Brazil pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 58 Brazil CRT market, by product, 2013 - 2024 (USD Million)
TABLE 59 Mexico CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 60 Mexico VADs market, by product, 2013 - 2024 (USD Million)
TABLE 61 Mexico ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 62 Mexico pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 63 Mexico CRT market, by product, 2013 - 2024 (USD Million)
TABLE 64 MEA CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 65 MEA VADs market, by product, 2013 - 2024 (USD Million)
TABLE 66 MEA ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 67 MEA pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 68 MEA CRT market, by product, 2013 - 2024 (USD Million)
TABLE 69 South Africa CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 70 South Africa VADs market, by product, 2013 - 2024 (USD Million)
TABLE 71 South Africa ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 72 South Africa pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 73 South Africa CRT market, by product, 2013 - 2024 (USD Million)
TABLE 74 Saudi Arabia CHF treatment devices market, by type, 2013 - 2024 (USD Million)
TABLE 75 Saudi Arabia VADs market, by product, 2013 - 2024 (USD Million)
TABLE 76 Saudi Arabia ICD’s market, by product, 2013 - 2024 (USD Million)
TABLE 77 Saudi Arabia pacemakers market, by product, 2013 - 2024 (USD Million)
TABLE 78 Saudi Arabia CRT market, by product, 2013 - 2024 (USD Million)
LIST OF FIGURES
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary (USD Million)
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Global geriatric population, 2012 - 2022 (Million)
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 CHF treatment devices market : Company market share, 2015
FIG. 14 Penetration & growth prospect mapping
FIG. 15 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 16 Porter’s Five Forces Analysis
FIG. 17 Congestive heart failure treatment devices market product outlook key takeaways
FIG. 18 Congestive Heart Failure Treatment Devices: Product movement analysis
FIG. 19 Ventricular assist devices market, 2013 - 2024 (USD Million)
FIG. 20 Left ventricular assist devices market, 2013 - 2024 (USD Million)
FIG. 21 Right ventricular assist devices market, 2013 - 2024 (USD Million)
FIG. 22 Biventricular assist devices market, 2013 - 2024 (USD Million)
FIG. 23 Counter pulsation devices market, 2013 - 2024 (USD Million)
FIG. 24 Implantable cardioverter defibrillators market, 2013 - 2024 (USD Million)
FIG. 25 Transvenous ICD’s market, 2013 - 2024 (USD Million)
FIG. 26 Subcutaneous ICDs market, 2013 - 2024 (USD Million)
FIG. 27 Pacemakers market, 2013 - 2024 (USD Million)
FIG. 28 Implantable pacemakers market, 2013 - 2024 (USD Million)
FIG. 29 External pacemakers market, 2013 - 2024 (USD Million)
FIG. 30 Cardiac resynchronization therapy market, 2013 - 2024 (USD Million)
FIG. 31 CRT-D market, 2013 - 2024 (USD Million)
FIG. 32 CRT-P market, 2013 - 2024 (USD Million)
FIG. 33 Regional market place: Key takeaways
FIG. 34 Regional outlook, 2015 & 2024
FIG. 35 North America CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 36 U.S. CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 37 Canada CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 38 Europe CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 39 UK CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 40 Germany CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 41 Asia Pacific CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 42 Japan CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 43 China CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 44 Latin America CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 45 Brazil CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 46 Mexico CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 47 MEA CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 48 South Africa CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 49 Saudi Arabia CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 50 Strategy framework
FIG. 51 Participant categorization
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary (USD Million)
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Global geriatric population, 2012 - 2022 (Million)
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 CHF treatment devices market : Company market share, 2015
FIG. 14 Penetration & growth prospect mapping
FIG. 15 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 16 Porter’s Five Forces Analysis
FIG. 17 Congestive heart failure treatment devices market product outlook key takeaways
FIG. 18 Congestive Heart Failure Treatment Devices: Product movement analysis
FIG. 19 Ventricular assist devices market, 2013 - 2024 (USD Million)
FIG. 20 Left ventricular assist devices market, 2013 - 2024 (USD Million)
FIG. 21 Right ventricular assist devices market, 2013 - 2024 (USD Million)
FIG. 22 Biventricular assist devices market, 2013 - 2024 (USD Million)
FIG. 23 Counter pulsation devices market, 2013 - 2024 (USD Million)
FIG. 24 Implantable cardioverter defibrillators market, 2013 - 2024 (USD Million)
FIG. 25 Transvenous ICD’s market, 2013 - 2024 (USD Million)
FIG. 26 Subcutaneous ICDs market, 2013 - 2024 (USD Million)
FIG. 27 Pacemakers market, 2013 - 2024 (USD Million)
FIG. 28 Implantable pacemakers market, 2013 - 2024 (USD Million)
FIG. 29 External pacemakers market, 2013 - 2024 (USD Million)
FIG. 30 Cardiac resynchronization therapy market, 2013 - 2024 (USD Million)
FIG. 31 CRT-D market, 2013 - 2024 (USD Million)
FIG. 32 CRT-P market, 2013 - 2024 (USD Million)
FIG. 33 Regional market place: Key takeaways
FIG. 34 Regional outlook, 2015 & 2024
FIG. 35 North America CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 36 U.S. CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 37 Canada CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 38 Europe CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 39 UK CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 40 Germany CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 41 Asia Pacific CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 42 Japan CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 43 China CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 44 Latin America CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 45 Brazil CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 46 Mexico CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 47 MEA CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 48 South Africa CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 49 Saudi Arabia CHF treatment devices market, 2013 - 2024 (USD Million)
FIG. 50 Strategy framework
FIG. 51 Participant categorization
